Artiva Biotherapeutics Inc (ARTV)
11.96
+0.74
(+6.60%)
USD |
NASDAQ |
Nov 05, 16:00
11.96
0.00 (0.00%)
After-Hours: 20:00
Artiva Biotherapeutics Total Assets (Quarterly): 90.16M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 90.16M |
| March 31, 2022 | 161.83M |
| December 31, 2021 | 169.93M |
| Date | Value |
|---|---|
| September 30, 2021 | 178.24M |
| December 31, 2020 | 29.23M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
29.23M
Minimum
Dec 2020
178.24M
Maximum
Sep 2021
125.88M
Average
161.83M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
| Oragenics Inc | 2.710M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 264.83M |
| Shareholders Equity (Quarterly) | -174.67M |
| Current Ratio | 6.355 |